Interestingly, CysLT1R antagonist treatment has been shown to inhibit growth of a series of human urological cancer cell lines (e.g., renal cell carcinoma, bladder cancer, prostate cancer, and testicular cancer) by inducing apoptosis [46]. The gene discussed is CYSLTR1; the disease is Familial prostate cancer.